Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Henderson Michael Thomas

SEC-identified person · CIK 1779990 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Apogee Therapeutics, Inc. APGE Director · Chief Executive Officer filed 2023–2026
Spyre Therapeutics, Inc. SYRE Director filed 2023–2026
Arya Sciences Acquisition Corp IV ARYD Director filed 2021–2024
Bridgebio Pharma, Inc. BBIO See Remarks filed 2019–2020

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.